United Therapeutics Corporation Operating Lease Liability
United Therapeutics Corporation (UTHR) had Operating Lease Liability of $12.20 million as of 2022-09-30, per its 10-Q filed 2022-11-02.
Discontinued › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiability · last filed 2022-11-02
- 2022-09-30: Operating Lease, Liability $12.20M.
- 2019-12-31: Operating Lease, Liability $4.80M.
- 2019-09-30: Operating Lease, Liability $4.70M.
- 2019-06-30: Operating Lease, Liability $6.90M.
| Period end | Operating Lease, Liability |
|---|---|
| 2022-09-30 | $12.20M 10-Q · filed 2022-11-02 |
| 2019-12-31 | $4.80M 10-K · filed 2020-02-26 |
| 2019-09-30 | $4.70M 10-Q · filed 2019-10-30 |
| 2019-06-30 | $6.90M 10-Q · filed 2019-07-31 |
| 2019-03-31 | $7.10M 10-Q · filed 2019-05-01 |
| 2019-01-01 | $8.20M 10-K · filed 2020-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |